WHY? This company stock at $ 4.51 beginning of August now at $ 1.43. Vical Inc. (VICL), the maker of experimental cancer drugs, fell the most in 20 years after saying its melanoma medicine failed to help patients in a clinical trial.
Everyone should be buying the #$%$ out of this stock. With the split now priced below March of 2009 levels. A balance sheet better than almost every industrial nation in the world.
HAVE A COKE AND A SMILE